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DNA virusHigh-level replication of polyomavirus BK (BKV) in kidney transplant recipients is associated with the
emergence of BKV variants with rearranged (rr) non-coding control region (NCCR) increasing viral early
gene expression and cytopathology. Cloning and sequencing revealed the presence of a BKV quasispecies
which included non-functional variants when assayed in a recombinant virus assay. Here we report that the
rr-NCCR of BKV variants RH-3 and RH-12, both bearing a NCCR deletion including the 5′ end of the
agnoprotein coding sequence, mediated early and late viral reporter gene expression in kidney cells.
However, in a recombinant virus they failed to produce infectious progeny despite large T-antigen and VP1
expression and the formation of nuclear virus-like particles. Infectious progeny was generated when the
agnogene was reconstructed in cis or agnoprotein provided in trans from a co-existing BKV rr-NCCR variant.
We conclude that complementation can rescue non-functional BKV variants in vitro and possibly in vivo.
© 2009 Elsevier Inc. All rights reserved.Introduction
Polyomavirus BK (BKV) infects more than 80% of the human
population and establishes latency in the renourinary tract. In approx-
imately 5–10% of healthy individuals BKV reactivates and gives
asymptomatic low-level urinary shedding (Egli et al., 2009; Polo et al.,
2004). However, reactivation in kidney or in bone marrow transplant
recipients is associated with much higher urine BKV loads and
progression to polyomavirus-associated nephropathy and hemorrhagic
cystitis, respectively (Dropulic and Jones 2008; Hirsch and Steiger 2003).
BKV has a ∼5000 basepairs circular double-stranded DNA genome
that can be divided into a regulatory, an early and a late coding region.
The regulatory or non-coding control region (NCCR) contains promot-
er/enhancer elements for the viral early and late genes and has been
arbitrarily divided into ﬁve consecutive sequence blocks designated
O142, P68, Q39, R63 and S63, where the numbers indicate the length in
basepairs (Markowitz and Dynan, 1988; Moens et al., 1995). The most
commonly found BKV strains in urine of immunocompetent individuals
have a linear anatomy of the O-P-Q-R-S blocks which is denoted
archetype or ww-NCCR (Egli et al., 2009; Rubinstein et al., 1987). Inldo).
tute for Cancer Research, The
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ll rights reserved.kidney transplant recipients, BKV strains with rearranged NCCRs (rr-
NCCR) have been found in urine, plasma and allograft biopsies (Azzi et
al., 2006; Chen et al., 2001; Gosert et al., 2008; Olsen et al., 2006; Perets
et al., 2009; Randhawa et al., 2003; Sharmaet al., 2007). The early region
encodes the important regulatory large tumour antigen (LT-ag) and the
supportive small T-ag (st-ag), while the late region encodes the
structural proteins VP1, VP2, VP3 as well as the agnoprotein.
Agnoprotein is a small basic protein abundantly expressed in the
cytoplasm during the late phase of the BKV life cycle, showing some
enrichment in the perinuclear region (Rinaldo et al., 1998). This
abundant expression pattern has also been observed in vivo in kidney
biopsies from patients with polyomavirus-associated nephropathy
(Leuenberger et al., 2007). The precise function of BKV agnoprotein is
presently unknown. Recently, the BKV agnoprotein was found to co-
localize with lipid droplets in the cytoplasm of Vero and primary
human tubular epithelial cells (Unterstab et al., revision). Another
study reports the detection of minute fractions of BKV agnoprotein in
the nucleus (Johannessen et al., 2008). Reports on agnoprotein
function in JCV and SV40 infection implicate a multitude of essential
functions in viral gene expression, virion assembly, maturation and
release (Khalili et al., 2005). The JCV agnoprotein has been reported to
facilitate nuclear egress of virions by destabilizing the nuclear
membrane through disrupting the interaction of HP1α with the
lamin B receptor, a transmembrane protein in the inner nuclear
membrane (Okada et al., 2005).
13M.R. Myhre et al. / Virology 398 (2010) 12–20In a previous study of BKV NCCR variants in urine and kidney
allograft biopsies from kidney transplant recipients (Olsen et al.,
2006), we detected two variants with rr-NCCRs and deletions in the 5′
part of the agnogene. NCCR variant RH-3 was found in a biopsy, while
RH-12 was found in the urine of another patient. Of note, both clinical
samples contained a number of additional NCCR variants with
complete agnogene. To the best of our knowledge, naturally occurring
variants without agnoprotein have not been reported for BKV, JCV or
SV40; thus, we conducted a functional analysis of RH-3 and RH-12
variants in kidney cells.Fig. 1. Characterization of RH-3 and RH-12 ampliﬁed from kidney transplant recipients. (a) S
ampliﬁed SacI fragment containing the NCCR was cloned into the BKV(Dunlop) backbone rep
different colours as indicated below. While archetype BKV NCCRWWT has one of each block
parts of the R-block, the S-block and the 5′ end of the agnogene. BKV(WWT) and BKV(Dunlo
the dual-reporter plasmid phRG with green (GFP) and red ﬂuorescence protein (RFP) expre
simulates early gene expression while green ﬂuorescence simulates late gene expression. Th
Elements Basic. Exposure time on all pictures: red 1/3 s and green 1 1/5 s. (c) BKV and cellu
recombinant RH-3, RH-12 or BKV(Dunlop). Polyclonal rabbit anti-sera directed against LT-a
used as primary antibodies. The housekeeping protein GAPDH is shown as a loading control.
p.t. with recombinant RH-3, RH-12 or BKV(Dunlop). Monoclonal mouse antibody anti-SV40
primary antibodies. Cell nuclei were stained with DRAQ5 (blue). (e) Demonstration of viru
labelled with polyclonal rabbit anti-sera directed against VP1 and protein-A-gold 10 nm (bResults
Characterization of RH-3 and RH-12
The promoter strength of RH-3 and RH-12 NCCR was ﬁrst
compared with the archetype ww-NCCR and the rearranged BKV
(Dunlop) NCCR using the dual reporter gene expression vector phRG
described by Gosert et al. (2008). Vero cells were transfected with
phRG-RH-3, phRG-RH-12, phRG-WW and phRG-Dunlop, and the
expression pattern examined 2 d p.t. The RH-3, RH-12 and BKVchematic illustration of the genome of the recombinant virus RH-3 and RH-12. The PCR
lacing the Dunlop NCCR. The transcription factor binding sequence blocks are shown in
and the complete agnogene, RH-3 and RH-12 have rearranged P- and Q-blocks and lack
p) were used as controls in most experiments. (b) NCCR activity. Vero cells 2 d p.t. with
ssion under the control of WW, RH-3, RH-12 or BKV(Dunlop) NCCR. Red ﬂuorescence
e pictures are taken using a Nikon TE2000 microscope equipped and processed with NIS
lar protein expression. Western blot on cell extracts from Vero cells 2 and 4 d p.t. with
g, VP1 or agnoprotein and a monoclonal mouse antibody directed against GAPDH were
(d) Subcellular localization BKV proteins. Immunoﬂuorescence staining of Vero cells 4 d
LT-ag (red) and polyclonal rabbit anti-sera directed against VP1 (green) were used as
s-like particles. IEM of Vero cells 4 d p.t. with RH-3 or RH-12. Virus-like particles were
lack dots).
Fig. 1 (continued).
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GFP expression while ww-NCCR showed the opposite pattern with
weak RFP and strong GFP (Fig. 1b). These results indicate that RH-3,
RH-12 and BKV(Dunlop) behave like other rr-NCCRs by having a
strong early but weak late expression while ww-NCCR have the
opposite expression pattern, as earlier demonstrated by Gosert et al.
(2008). We concluded that RH-3 and RH-12 NCCRs were functional
promoters with similar characteristics as previously described for
other rr-NCCRs.
Next we investigated the expression of BKV proteins from RH-3
and RH-12 recombinant viruses. Vero cells were transfected with
religated genomes, cell extracts harvested 2 and 4 d p.t. and cells were
ﬁxed 4 d p.t. Again BKV(Dunlop) was included as a positive control.
Western blot demonstrated production of LT-ag and VP1 from all
three strains, but only BKV(Dunlop) produced agnoprotein (Fig. 1c).This was conﬁrmed on the single-cell level by immunoﬂuorescence
staining, which also demonstrated that RH-3 and RH-12 transfected
cells have the same nuclear localisation of VP1 and LT-ag as BKV
(Dunlop) (Fig. 1d).
To examine the ability of RH-3 and RH-12 recombinant viruses to
produce infectious viral particles, Vero cell supernatants 4 d p.t. were
seeded on permissive HUV-EC-C. When supernatants from RH-3 or
RH-12 transfected cells were used as inoculum, immunoﬂuorescence
staining with VP1 and LT-ag antibodies 4 days post-infection (d p.i.)
was negative while BKV(Dunlop) supernatant resulted in a high
percentage of infected cells (data not shown). In order to ﬁnd out if the
nucleus of RH-3 and RH-12 transfected Vero cells contained only VP1
or also viral particles, immune electron microscopy with gold labelled
VP1 antibodies was performed. Virus-like particles were detected in
the nucleus of both RH-3 and RH-12 transfected cells (Fig. 1e).
Fig. 2. Trans-complementation. (a) Schematic presentation of constructs. RH-12 was
released from the vector and religated before transfection into Vero cells. The same was
done for RH-3 (not shown). pRH-7, pRH-9 and pWW all contain the complete BKV
genome in a vector. Since the genome is cloned via a restriction site in VP1 the VP1 gene
is interrupted. (b) BKV protein expression. Western blot on cell extracts from Vero cells
4 d p.t. with RH-12 and the BKV genomes in vector (pWW, pRH-9 or pRH-7) or only the
BKV genomes in vector. Polyclonal rabbit anti-sera directed against LT-ag, VP1 and
agnoprotein were used as primary antibodies. (c) Detection of infectious progeny.
Supernatants harvested 4 d p.t. from Vero cells co-transfected with RH-12 and pRH-7 or
RH-3 and pRH-7 were seeded onto HUV-EC-C. Immunoﬂuorescence staining with
monoclonal mouse antibody anti-SV40 LT-ag (red) and polyclonal rabbit anti-serum
directed against VP1 (green) was performed 4 d p.i. Cell nuclei were stained with
DRAQ5 (blue).
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but simply not released into the supernatant, RH-3, RH-12 and BKV
(Dunlop) transfected Vero cells were subjected to three cycles of
freezing and thawing to destroy cellular membranes and liberate viral
particles. This lysate was then used to inoculate HUV-EC-C. Immuno-
ﬂuorescence staining with antibodies for VP1 and LT-ag 4 d p.i. only
revealed stained cells inwells inoculatedwith BKV(Dunlop) lysate but
not with RH-3 or RH-12 recombinants (data not shown).
We concluded that deletion in the 5′ part of the agnogene in RH-3
and RH-12 allowed for LT-ag and VP1 protein expression, but not for
agnoprotein expression. LT-ag and VP1 showed the expected nuclear
localization and VP1 assembled into virus-like particles. However, RH-
3 and RH-12 did not release infectious progeny into cell culture
supernatants, and the intranuclear virus-like particles turned out to
be non-infectious when artiﬁcially released from the host cells.
Inﬂuence of agnoprotein given in trans to RH-3 and RH-12
To investigatewhether providing agnoprotein in transwould allow
for RH-3 and RH-12 to generate infectious viral particles, we co-
transfected RH-3 or RH-12 together with three different genomic BKV
plasmids corresponding to the archetype pWWT and the rr-NCCR BKV
pRH-9 and pRH-7. In these three plasmids the VP1 genewas disrupted
by the vector sequence, but the remaining viral genes including the
agnoprotein coding sequence was left intact (Fig. 2a). Supernatants
and cell extractswere harvested4dp.t. The cell extractswere analyzed
by Western blot using antibodies against LT-ag, VP1 and agnoprotein.
While single transfected RH-12 cells only produced LT-ag and VP1, co-
transfected cells also expressed agnoprotein (Fig. 2b). Similar results
were also obtained for co-transfections with RH-3 (data not shown).
By contrast, no VP1 was detected in the control cells transfected with
pWWT, pRH-9 or pRH-7 bearing the disrupted VP1 gene.
Then, the production of infectious particles in Vero cells was
examined by seeding the supernatants onto HUV-EC-C. Immunoﬂu-
orescence staining with antibodies directed against LT-ag and VP1, or
LT-ag and agnoprotein, was performed 4 d p.i. This time, infection
could be demonstrated in HUV-EC-C. Importantly, no agnoprotein but
only LT-ag and VP1 was detected indicating that the infectious
particles must have originated from RH-3 and RH-12 and not from the
helper plasmid providing agnoprotein in trans. Supernatants obtained
from co-transfection with pRH-7 gave rise to a higher number of BKV
expressing cells, and therefore contained higher viral load than
supernatants from co-transfection with pRH-9 or pWWT (Fig. 2c, and
data not shown). Of note, the recombinant RH-7was recently found to
replicate better than the recombinant RH-9 and BKV WWT in both
Vero cells and RPTECs (Olsen et al., 2009). We concluded that
providing agnoprotein and LT-ag in trans complemented the deﬁ-
ciency of RH-3 and RH-12 to produce infectious viral particles. Since
LT-ag and VP1 are made by RH-3 and RH-12, complementation of the
absent agnoprotein was most likely to provide the necessary
contribution.
The effect of replacing the truncated agnogene with a complete agnogene
— characterization of RH-3-agno and RH-12-agno
To investigate directly whether the addition of agnoprotein would
be sufﬁcient for infectious virus production of RH-3 and RH-12, we
reconstructed RH-3 and RH-12 with a complete agnoprotein coding
sequence, denoted RH-3-agno and RH-12-agno. Vero cells were then
transfected with RH-3-agno and RH-12-agno genomes using RH-3,
RH-12 and BKV(Dunlop) as controls. Cell extracts were harvested 4 d
p.t. and Western blot was performed using antibodies against LT-ag,
VP1 and agnoprotein. As shown in Fig. 3a, both RH-3-agno and RH-12-
agno expressed LT-ag, VP1 and agnoprotein. Immunoﬂuorescence
staining 4 d p.t. also demonstrated normal cytoplasmic agnoprotein
distribution (Fig. 3b). The production of infectious progeny wasexamined by seeding supernatants from Vero cells 4 d p.t. on HUV-EC-
C. Immunoﬂuorescence staining with antibodies to LT-ag and
agnoprotein revealed infected cells when supernatants from transfec-
tions with RH-3-agno (Fig. 3c), RH-12-agno (data not shown) or BKV
(Dunlop) (data not shown) but not from RH-3 or RH-12 were
inoculated onto HUV-EC-C. In agreement with this, qPCR on DNase I
treated Vero cell supernatants 4 d p.t. only detected BKV load levels
above input for RH-3-agno, RH-12-agno and BKV(Dunlop) (Fig. 3d).
16 M.R. Myhre et al. / Virology 398 (2010) 12–20We concluded that the presence of agnoprotein enabled RH-3 and RH-
12 to produce and release infectious virus into the cell culture
supernatant.
BKV agnoprotein and HP1α
To investigate whether or not BKV agnoprotein facilitated nuclear
egress by interacting with proteins of the nuclear membrane as
reported previously for JCV agnoprotein (Okada et al., 2005), we
infected primary RPTECs with BKV(Dunlop) and stained for agnopro-
tein and lamin A/C. As shown in Fig. 4a and a′, we could not detect co-
localization of both proteins. Lamin A/C staining was clearly nuclear
while the agnoprotein staining was exclusively cytoplasmic. Interest-
ingly, the staining pattern of lamin was different in BKV infected and
uninfected cells. In infected cells, themajority of lamin accumulated at
the nuclear rim while in uninfected cells, the lamin was present
throughout the nucleoplasm (Fig. 4a, see arrowheads). Next, we
investigated if agnoprotein and HP1α co-localized. HP1αwas present
throughout the nucleoplasm with the exception of some distinct
unstained areas, but we detected no co-localization with agnoprotein
(Fig. 4b and b′). Immunostaining with VP1 and HP1α revealed that
the areas unstained by HP1α had strong VP1 staining, probably
indicating areas of virion assembly (Fig. 4c). However, LT-ag and
HP1α had a common staining pattern and partly overlapped in the
VP1-free intranuclear areas (Fig. 4d). Immunostaining for lamin A/C
and HP1α conﬁrmed the co-localization of the two proteins at the
outer nuclear rim (Fig. 4e). We concluded that the role of BKV
agnoprotein in facilitating the generation and release of infectious
progeny could not be explained by an interaction with the lamin A/C
or HP1α in the nuclear membrane.
Discussion
The expression of BKV agnoprotein was demonstrated more than
10 years ago (Rinaldo et al., 1998), but still the exact function is
unknown for this small abundant protein found in the cytoplasm of
BKV infected cells in vitro and in vivo (Leuenberger et al., 2007).
The two BKV strains with rr-NCCR and deletion in the 5′ end of the
agnogene were found in a urine sample (RH-12) and in a kidney
allograft biopsy (RH-3) from different kidney transplant recipients.
Reporter assay analysis of the rr-NCCRs showed promoter activities
similar to the highly replicating BKV(Dunlop) strain, with a strong
early but weak late promoter activity. Replacing the rr-NCCR of the
BKV(Dunlop) with the corresponding rr-NCCR of RH-3 and RH-12
conﬁrmed the functionality through production of both early LT-ag
and late VP1 proteins. While the production of early proteins was
similar to BKV(Dunlop), VP1 expression was slightly lower and there
was no agnoprotein detectable. The absence of agnoprotein was
coupled to the lack of infectious progeny, both intracellularly and
extracellularly, suggesting that agnoprotein plays a role in the
generation of infectious virus particles. Electron microscopyFig. 3. Characterization of RH-3-agno and RH-12-agno. (a) BKV protein expression.
Western blot on cell extracts from Vero cells 4 d p.t. with RH-3, RH-3-agno, RH-12, RH-
12-agno, BKV(Dunlop) or mock. Polyclonal rabbit sera directed against LT-ag, VP1 and
agnoprotein were used as primary antibodies. (b) Subcellular localization of BKV
proteins. Immunoﬂuorescence staining of Vero cells 4 d p.t. with RH-3-agno, RH-12-
agno and BKV(Dunlop). Monoclonal mouse antibody anti-SV40 LT-ag (red) and
polyclonal rabbit anti-serum directed against agnoprotein (green) were used as
primary antibodies. Cell nuclei were stained with DRAQ5 (blue). (c) Demonstration of
infectious particles. Supernatants from Vero cells 4 d p.t. with RH-3-agno were
harvested and seeded onto HUV-EC-C. Immunoﬂuorescence staining 4 d p.i. with
monoclonal mouse antibody anti-SV40 LT-ag (red) and polyclonal rabbit anti-serum
directed against agnoprotein (green) was used as primary antibodies. Cell nuclei were
stained with DRAQ5 (blue). (d) Release of viral progeny. Quantitative PCR on DNase I
treated supernatants from RH-3, RH-3-agno, RH-12, RH-12-agno and BKV(Dunlop)
transfected Vero cells 1 and 4 d p.t. Data are presented as BKV load (Geq/ml). The DNA
load at 1 d p.t. is input DNA.
Fig. 4. Co-localization study of BKV agnoprotein with lamin A/C and HP1α.
Immunoﬂuorescence staining of RPTECs 3 d p.i. with BKV(Dunlop). The following
primary antibodies were used: (a and a′) anti-agnoprotein and anti-lamin A/C
(monoclonal), (b and b′) anti-agnoprotein and anti-HP1α, (c) anti-VP1 and anti-HP1α,
(d) anti-LT-ag and anti-HP1α, (e) anti-lamin A/C (polyclonal) and anti-HP1α.
Secondary antibody anti-rabbit conjugated with Alexa ﬂuor 488 (giving green
ﬂuorescence) is labelled with (g), while anti-mouse conjugated Alexa ﬂuor 568 (giving
red ﬂuorescense) is labelled with (r). In (a) the upper arrowhead indicate an uninfected
cell while the lower arrowhead indicate an infected cell.
17M.R. Myhre et al. / Virology 398 (2010) 12–20documented the presence of virus-like particles in Vero cells
transfected with RH-3 or RH-12 DNA. Despite this similar morphol-
ogy, infectivity was not found suggesting that other critical steps had
not occurred. One such step could be packaging of the viral genome. In
accordancewith this, no viral DNA above input level could be detected
in the cell culture supernatants by qPCR. For JCV, mutation of the
agnoprotein phosphorylation sites was enough to prevent encapsida-
tion of viral DNA (Sariyer et al., 2006). In contrast, this was not found
when a phosphorylation site in BKV agnoprotein was mutated
(Johannessen et al., 2008). For SV40 packing of viral DNA has been
associated with VP2 and VP3 function (Roitman-Shemer et al., 2007).
As SV40, BKV has two classes of late RNAs, 16S and 19S, which are
generated by alternative splicing from a common pre-mRNA. While
the 19S RNA is translated to yield both VP2 and VP3, the 16S RNA
species is translated to yield VP1 and agnoprotein. The partially
deleted agnogene should therefore not affect the expression of VP2
and VP3. However, studies of SV40 demonstrate that a minor fraction
of agnoprotein is made from the 19S RNA, and that an open reading
frame for agnogene reduce the synthesis of VP2 and VP3 three- to
ﬁve-fold (Good et al., 1988). If this is the same for BKV, we would
expect a slightly increased VP2 and VP3 expression from RH-3 and
RH-12.
Addition of the complete agnoprotein coding sequence to RH-3
and RH-12 enabled RH-3-agno and RH-12-agno to produce infectious
virus. Moreover, co-transfection with genomic BKV plasmids corres-ponding to the archetype pWWT or the rr-NCCR BKV pRH-9 and pRH-
7, in which the VP1 gene was disrupted, provided agnoprotein in
trans and allowed for completion of the BKV life cycle. This
observation indicates that agnoprotein-deﬁcient BKV genomes can
be effectively rescued by co-transfection in vitro. Although our results
suggest that BKV agnoprotein facilitate the assembly and/or
maturation of infectious virions, release may also be affected.
However the precise involvement in release must be different than
for JCV agnoprotein, which is reported to act on the nuclear
membrane. More importantly, our results suggest that trans-comple-
mentation by superinfection could be a mechanism to rescue non-
functional BKV variants in vivo.
These are the only reported natural occurring BKV variants with
deletion of the 5′ end of the agnoprotein coding sequence eliminating
agnoprotein production. BKV(AS), a variant detected in the urine of a
pregnant woman but ﬁrst sequenced after several passages in cell
culture, contain a deletion affecting the start codon of the agnogene
(Tavis et al., 1989). However, Tavis et al. predicted an alternative in
frame start codon located upstream in the S block. This start codon
would give an agnoprotein with eight additional amino acids in the N-
terminal part. By transfecting BKV(AS) DNA into Vero cells, we
conﬁrmed that BKV(AS) is able to express agnoprotein with normal
cytoplasmic localization (Myhre and Rinaldo, unpublished data).
Several BKV genomes with a deletion of nine nucleotides in the 3′
end of the agnogene have been reported in the urine of non-
immunocompromised individuals (Yogo et al., 2008). No frame shifts
were created; therefore these genomes could probably encode
truncated agnoproteins with structural changes. Also a JCV variant
with deletion in the 3′end of agnogene has been discovered in a urine
sample (Jobes et al., 1999).
Agnoprotein deletion mutants have been reported for SV40 after
serial passage in cell cultures at high multiplicities of infection. The
SV40 mutants without agnoprotein expression replicate their DNA
with wild-type kinetics but release mature virions inefﬁciently and as
a consequence produce small plaques (Hou-Jong et al., 1987; Ng et al.,
1985; Resnick and Shenk 1986). During the last years three additional
human polyomavirus have been isolated: KI virus (KIV) andWU virus
(WUV) from respiratory tract samples (Allander et al., 2007; Gaynor et
al., 2007) andMC virus (MCV) fromMerkel cell carcinoma (Feng et al.,
2008). These newpolyomaviruses have a genome organization similar
to BKV and JCV but seem to lack an open reading frame corresponding
to the agnogene. This indicates that they can sustain the life cycle
without the agnoprotein. Recently, BKV(Dunlop) with an introduced
point mutation in the agnogene start codon, preventing agnoprotein
production, was found to produce infectious progeny in Vero cells but
only at very low yields (Johannessen et al., 2008). Thismutant had a 2-
fold increased expression of both LT-ag and VP1 2 d p.t. of Vero cells.
For RH-3 andRH-12,we did notﬁnd a higher LT-ag andVP1 expression
compared to RH-3-agno and RH-12-agno at 4 d p.t. However, natural
variants RH-3 and RH-12 differ from this constructed Dunlop mutant
by lacking theﬁrst part of the agnogene and by containing a NCCRwith
different organization. Interestingly a point mutation in the JCV
agnogene start codonwas reported to negatively affect the expression
of LT-ag and VP1 (Akan et al., 2006). Clearly, more detailed studies are
needed to unravel the functional role(s) of agnoprotein.
When BKV NCCR activity was studied by the use of the bi-
directional red–green reporter assay, both RH-3 andRH-12NCCRwere
found to have promoter activities akin to the BKV(Dunlop) NCCR.
Indeed, BKV(Dunlop) has a rr-NCCR and behaves similar to majority
species rr-NCCR emerging in recipients with polyomavirus-associated
nephropathy (Gosert et al., 2008) by showing a strong early, but weak
late promoter activity. The corresponding recombinant BKV variants
also showed increased LT-ag expression and the highest replication
rates in vitro. Our results on the RH-3 and RH-12 clearly demonstrate
that a deletion in agnoprotein coding sequence overrules the apparent
advantageous NCCR and that a strong early promoter is not enough to
18 M.R. Myhre et al. / Virology 398 (2010) 12–20be successful, unless rescued by agnoprotein complementation in
trans. Trans-complementation is not unique to BKV infection and has,
for example, also been described for cytolomegalovirus where viral
ﬁtness was affected (Cicin-Sain et al., 2005).
In conclusion, we have found that natural BKV variants with
deletions in the coding sequence of agnoprotein make virus-like
particles but don't release infectious progeny into Vero cell super-
natants. Addition of agnoprotein in trans or replacement of the
truncated agnogene with a complete agnogene leads to release of
infectious progeny. Our results suggest that BKV agnoprotein
facilitates assembly and/or maturation of virions and that a possible
involvement in release is different than suggested for JCV agnopro-
tein. They also imply that trans-complementation can rescue non-
functional BKV variants in vivowhich would explain their detection in
a host with other BKV variants composing the BKV quasispecies.
Materials and methods
Cell cultures
Vero cells, derived from the kidney of an African green monkey
(ATTC CRL 1587, www.atcc.org) were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) (Invitrogen, www.invitrogen.
com) containing 10% fetal bovine serum (Invitrogen). Human
umbilical vein endothelial cells (HUV-EC-C, ATTC CRL 1730) were
grown in Kaighn's FK12 medium (Invitrogen) containing 10% fetal
bovine serum and endothelial cell growth factor (ECGF E-9640;
Sigma, www.sigmaaldrich.com) according to the manufactures
descriptions. Primary human renal tubule epithelial cells (RPTECs)
(Lonza, www.lonzabioscience.com) were propagated as described by
the manufacturer. All experiments were performed with RPTECs
passage 4.
Viruses and plasmids
The generation of the recombinant viruses RH-3 (GenBank
FJ940853) and RH-12 (GenBank FJ940861) from kidney transplant
recipients is earlier described (Olsen et al., 2006). Brieﬂy, RH-3 andRH-
12 NCCRs (Fig. 1a) were ampliﬁedwith primers 1 and 2 (Table 1) from
a kidney allograft biopsy and urine sample, respectively. After SacI
(NEB, www.NEB.com) digestion, the NCCR fragment was cloned into
partial SacI digestedpBKV(34-2) (BKV(Dunlop), ATTC 45025), thereby
replacing the BKV(Dunlop) NCCR. The generation of RH-3 and RH-12
with complete gene encoding agnoprotein, RH-3-agno and RH-12-
agno, was performed with gene splicing by overlap extension (SOE)
(Horton et al., 1989). All the primers used are listed in Table 1. In short,
RH-3 and RH-12 NCCR were PCR ampliﬁed by primers 1 and 3 (RH-3)
or primers 1 and 5 (RH-12). Next, the ﬁrst 145 nucleotides of the
agnogenewere ampliﬁed from pBKV(34-2) by primers 4 and 2 (RH-3)
or primers 6 and2 (RH-12) and subsequently joined to theRH-3 or RH-
12 NCCR fragment, respectively, with a PCR using primers 1 and 2. The
SacI NCCR fragment of RH-3-agno and RH-12-agno was ﬁnally clonedTable 1
Primers.
No Name DNA sequence (5′–3′)
1 GPPY1 CCAAAATCAGGCTGATGAGC
2 GPPY2 TTCCCGTCTACACTGTCTTC
3 RH-3r GCTGGCGCAGAACCATTGTGTTTATTTG
4 RH-3f AGAATTCTCAAATAAACACAATGGTTCT
5 RH-12r GCTGGCGCAGAACCATTTGTGTTTATTT
6 RH-12f AGAATTCTCAAATAAACACAAATGGTT
7 NCCR3 AAAAACGCGTCATTTTTGCAAAAATTGC
8 RH-3NCCR4 TTTTGCGCGCCTGGCGCAGAACCATTGT
9 RH-12NCCR4 TTTTGCGCGCCTGGCGCAGAACCATTTG
10 NCCR4 TTTTGCGCGCCTGGCGCAGAACCATGGinto pBKV(34-2) as described for RH-3 and RH-12. The integrity of the
newplasmidswas conﬁrmedby sequencing. BKV(Dunlop) is known to
replicate in Vero, RPTEC andHUV-EC-C (Bernhoff et al., 2008; Gosert et
al., 2008;Grinde et al., 2007;Olsen et al., 2009), andwas therefore used
as a positive control. In order to make infectious viruses for
transfection, the recombinant virus DNAwas released from the vector
by BamHI (NEB) digestion and religated with T4 DNA ligase (NEB).
Two additional recombinant viruses, RH-7 and RH-9 (Olsen et al.,
2006; Olsen et al., 2009), and the archetypeWWT (GenBankM34048)
were included in some experiments and the generation of these is as
described for RH-3 and RH-12. These variants were only used
incorporated into their vectors (pBR322 for RH-7 and RH-9, and
pGEM3Zf(-1) for WWT) and then denoted pRH-7, pRH-9 and pWWT.
The generation of the dual-reporter plasmid phRG is earlier
described (Gosert et al., 2008). In this plasmid the red ﬂuorescent
protein (RFP) and the green ﬂuorescent protein (GFP) are in the same
position as the early and late genes, respectively, and both are under
control of the inserted BKV NCCR. To make phRG-RH-3 and phRG-RH-
12, theNCCR sequenceswere ampliﬁed from the respective plasmids by
PCRusingprimers 7 and 8 or 7 and9. TheMluI–BssHII-cleaved amplicon
was then ligated into phRG digested with the same enzymes. As a
positive control phRG-Dunlop wasmade by PCR using primer 7 and 10.
The construct phRG-WWwas made previously (Gosert et al., 2008).
Sequencing
Cycle sequencing was performed in both directions with primers 1
and 2 (Table 1) using the BigDye Terminator version 3.1 Cycle
Sequencing Kit (Applied Biosystems, www.appliedbiosystems.com).
Sequencing reactions were analyzed on an ABI377 Prism Sequencer
(Applied Biosystems).
Transient transfection
Transfection of Vero cells with religated RH-3 and RH-12 genomes
or complete plasmids were done using Lipofectamine 2000 (Invitro-
gen) according to the instructions of the manufacturer. Cells were
transfected with 200 or 400 ng of religated BKV DNA per 0.8 cm2 well
(chamber slides) or 2 cm2 well, respectively. For co-transfections of
2 cm2 wells, 1200 ng of BKV plasmids (pWW, pRH-7 or pRH-9) and
400 ng of religated RH-3 or RH-12 DNAwere used, giving a ratio of 3:1.
Supernatants were collected 1, 2, and 4 days post-transfection (d p.t.),
while cells were harvested 2 and 4 d p.t.
Quantitative PCR for BKV DNA
To quantitate extracellular BKV DNA, cell culture supernatants
were harvested 1 and 4 d p.t. To remove uncapsidated DNA, DNase I
(NEB) treatmentwas performed for 1 h followed by 5min inactivation
at 100°C. The supernatant was diluted 1:10 in dH2O and quantitative
BKV PCR was performed with primers and probes targeting the LT-ag
(Hirsch et al., 2001).Size Reference
20 (Olsen et al., 2009)
20 (Sundsfjord et al., 1994)
AGAATTCTAGGGC 41
GCGCCAGCTGTC 40
GAGAATTCTAGGGC 42
CTGCGCCAGCTGTC 41
AAAAGAATAGG 39 (Gosert et al., 2008)
GTTTA 33
TGTTTA 34
CCTT 31 (Gosert et al., 2008)
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Titration of viral infectivity was performed on HUV-EC-C, which
in contrast to Vero cells are highly permissive for BKV infection
(Hanssen et al., 2005). Cell supernatants harvested 4 d p.t. from Vero
cells were seeded onto HUV-EC-C. Two hours post-infection (p.i.),
cells were washed once in PBS and complete medium was added.
Four days p.i., cells were ﬁxed and immunoﬂuorescence staining
conducted. In some experiments transfected Vero cells were
subjected to three rounds of freezing and thawing before addition
to HUV-EC-C.
Western blotting
Vero cells were harvested in 40 μl of lysis buffer (0.25 M
dithiothreitol, 1:1 NuPAGE lithium dodecyl sulfate sample buffer,
and double distilled H2O), heated to 70°C for 10min, and sonicated for
5 s. The samples were stored in −80°C until 17 μl protein lysate was
separated by SDS PAGE (Invitrogen) and electrotransferred onto
Millipore Immobilon-FL blotting-membrane. The detection of viral
proteins was performed with monoclonal anti-SV40 LT-ag antibody
(Ab-2 Pab416; 1:100, Chemicon, www.chemicon.com) or polyclonal
rabbit antiserum directed against LT-ag (1:2000), VP1 (1:10,000), or
agnoprotein (1:10,000) (Grinde et al., 2007; Hey et al., 1994; Rinaldo
et al., 1998) and GAPDH (Ab8245; 1:5000, Abcam, www.abcam.com)
as earlier described (Bernhoff et al., 2008).
Immunoﬂuorescence staining
Cells were ﬁxed in 4% paraformaldehyde and permeabilised in
methanol before blocking with 3% goat-serum/PBS followed by
subsequently incubation with primary (37 °C) and secondary (r.t.)
antibodies for 30 min. Primary antibodies were monoclonal anti-SV40
LT-ag antibody (Ab-2 Pab416) (1:100), HP1α (MAB3584; 1:1000,
Chemicon) and Lamin A/C (Sc-7292; 1:100, Santa Cruz biotechnology,
www.scbt.com) or rabbit polyclonal IgG Lamin A/C (Sc-20681; 1:100,
Santa Cruz biotechnology) and polyclonal rabbit antiserum directed
against agnoprotein or VP1(1:800). The secondary antibodies were
anti-mouse conjugated with AlexaFluor 568 and anti-rabbit conjugat-
ed with AlexaFluor 488 (1:500; Molecular Probes, www.invitrogen.
com). Nuclei were labelled with DRAQ5™ (Biostatus, www.biostatus.
com). Images were taken using a Zeiss Axiovert 200 microscope (Carl
Zeiss MicroImaging, www.zeiss.com) equipped with a LSM510
confocal module and processed using LSM5 software version 3.2
(Carl Zeiss MicroImaging, Inc.).
Immunoelectron microscopy (IEM)
Transfected Vero cells were ﬁxed 4 d p.t. with 4% paraformal-
dehyde, washed in 0.12% glycin, scraped and pelleted in 12%
gelantine. Next, the cell pellets were placed in 2.3 M sucrose
overnight and subsequently cut in cubes, before mounted on cryo
pins. The pellets were then frozen by immersion in liquid nitrogen
and sectioned using a Leica EM UC6 Ultramicrotome. Sections
were submerged in 1% cold water ﬁsh skin gelantine overnight.
Finally, the sections were incubated with polyclonal rabbit serum
directed against VP1 and then with protein-A-gold (10 nm). The
specimens were contrasted with a mixture of uranyl acetate and
methylcellulose and examined by a Jeol 1010 transmission electron
microscope.
Acknowledgments
We wish to thank Kenneth Bowitz Larsen at the Bioimaging Core
Facility and Randi Olsen at the Department of Electron Microscopy,
both at the University of Tromsø for excellent technical assistance.References
Akan, I., Sariyer, I.K., Bifﬁ, R., Palermo, V., Woolridge, S., White, M.K., Amini, S., Khalili, K.,
Safak, M., 2006. Human polyomavirus JCV late leader peptide region contains
important regulatory elements. Virology 349, 66–78.
Allander, T., Andreasson, K., Gupta, S., Bjerkner, A., Bogdanovic, G., Persson, M.A.,
Dalianis, T., Ramqvist, T., Andersson, B., 2007. Identiﬁcation of a third human
polyomavirus. J. Virol. 81, 4130–4136.
Azzi, A., de Santis, R., Salotti, V., Di Pietro, N., Ginevri, F., Comoli, P., 2006. BK virus
regulatory region sequence deletions in a case of human polyomavirus associated
nephropathy (PVAN) after kidney transplantation. J. Clin. Virol. 35, 106–108.
Bernhoff, E., Gutteberg, T.J., Sandvik, K., Hirsch, H.H., Rinaldo, C.H., 2008. Cidofovir
inhibits polyomavirus BK replication in human renal tubular cells downstream of
viral early gene expression. Am. J. Transp. 8, 1413–1422.
Chen, C.H., Wen, M.C., Wang, M., Lian, J.D., Wu, M.J., Cheng, C.H., Shu, K.H., Chang, D.,
2001. A regulatory region rearranged BK virus is associated with tubulointerstitial
nephritis in a rejected renal allograft. J. Med. Virol. 64, 82–88.
Cicin-Sain, L., Podlech, J., Messerle, M., Reddehase, M.J., Koszinowski, U.H., 2005.
Frequent coinfection of cells explains functional in vivo complementation
between cytomegalovirus variants in the multiply infected host. J. Virol. 79,
9492–9502.
Dropulic, L.K., Jones, R.J., 2008. Polyomavirus BK infection in blood and marrow
transplant recipients. Bone Marrow. Transplant. 41, 11–18.
Egli, A., Infanti, L., Dumoulin, A., Buser, A., Samaridis, J., Stebler, C., Gosert, R., Hirsch,
H.H., 2009. Prevalence of polyomavirus BK and JC infection and replication in 400
healthy blood donors. J. Infect. Dis. 199, 837–846.
Feng, H., Shuda, M., Chang, Y., Moore, P.S., 2008. Clonal integration of a polyomavirus in
human Merkel cell carcinoma. Science 319, 1096–1100.
Gaynor, A.M.,Nissen,M.D.,Whiley,D.M.,Mackay, I.M., Lambert, S.B.,Wu,G., Brennan,D.C.,
Storch, G.A., Sloots, T.P., Wang, D., 2007. Identiﬁcation of a novel polyomavirus from
patients with acute respiratory tract infections. PLoS Pathog. e64, 3.
Good, P.J., Welch, R.C., Barkan, A., Somasekhar, M.B., Mertz, J.E., 1988. Both VP2 and VP3
are synthesized from each of the alternative spliced late 19S RNA species of simian
virus 40. J. Virol. 62, 944–953.
Gosert, R., Rinaldo, C.H., Funk, G.A., Egli, A., Ramos, E., Drachenberg, C.B., Hirsch, H.H.,
2008. Polyomavirus BK with rearranged noncoding control region emerge in vivo
in renal transplant patients and increase viral replication and cytopathology. J. Exp.
Med. 205, 841–852.
Grinde, B., Gayorfar, M., Rinaldo, C.H., 2007. Impact of a polyomavirus (BKV) infection
on mRNA expression in human endothelial cells. Virus Res. 123, 86–94.
Hanssen, R.C., Hansen, H., Traavik, T., 2005. Human endothelial cells allow passage of an
archetypal BK virus (BKV) strain-a tool for cultivation and functional studies of
natural BKV strains. Arch. Virol. 150, 1449–1458.
Hey, A.W., Johnsen, J.I., Johansen, B., Traavik, T., 1994. A two fusion partner system for
raising antibodies against small immunogens expressed in bacteria. J. Immunol.
Methods 173, 149–156.
Hirsch, H.H., Steiger, J., 2003. Polyomavirus BK. Lancet Infect. Dis. 3, 611–623.
Hirsch, H.H., Mohaupt, M., Klimkait, T., 2001. Prospective monitoring of BK virus load
after discontinuing sirolimus treatment in a renal transplant patient with BK virus
nephropathy. J. Infect. Dis. 184, 1494–1496.
Horton, R.M., Hunt, H.D., Ho, S.N., Pullen, J.K., Pease, L.R., 1989. Engineering hybrid
genes without the use of restriction enzymes: gene splicing by overlap extension.
Gene 77, 61–68.
Hou-Jong, M.H., Larsen, S.H., Roman, A., 1987. Role of the agnoprotein in regulation of
simian virus 40 replication and maturation pathways. J. Virol. 61, 937–939.
Jobes, D.V., Friedlaender, J.S., Mgone, C.S., Koki, G., Alpers, M.P., Ryschkewitsch, C.F.,
Stoner, G.L., 1999. A novel JC virus variant found in the Highlands of Papua New
Guinea has a 21-base pair deletion in the agnoprotein gene. J. Hum. Virol. 2,
350–358.
Johannessen, M., Myhre, M.R., Dragset, M., Tummler, C., Moens, U., 2008. Phosphor-
ylation of human polyomavirus BK agnoprotein at Ser-11 is mediated by PKC and
has an important regulative function. Virology 379, 97–109.
Khalili, K., White, M.K., Sawa, H., Nagashima, K., Safak, M., 2005. The agnoprotein of
polyomaviruses: a multifunctional auxiliary protein. J. Cell. Physiol. 204, 1–7.
Leuenberger, D., Andresen, P.A.,Gosert, R., Binggeli, S., Strom,E.H., Bodaghi, S., Rinaldo, C.H.,
Hirsch, H.H., 2007. Human Polyomavirus type 1 (BK virus) Agnoprotein is abundantly
expressed, but immunologically ignored. Clin. Vaccine Immunol. 14, 959–968.
Markowitz, R.B., Dynan, W.S., 1988. Binding of cellular proteins to the regulatory region
of BK virus DNA. J. Virol. 62, 3388–3398.
Moens, U., Johansen, T., Johnsen, J.I., Seternes, O.M., Traavik, T., 1995. Noncoding control
region of naturally occurring BK virus variants: sequence comparison and
functional analysis. Virus Genes 10, 261–275.
Ng, S.C., Mertz, J.E., Sanden-Will, S., Bina, M., 1985. Simian virus 40 maturation in cells
harboring mutants deleted in the agnogene. J. Biol. Chem. 260, 1127–1132.
Okada, Y., Suzuki, T., Sunden, Y., Orba, Y., Kose, S., Imamoto, N., Takahashi, H., Tanaka, S.,
Hall, W.W., Nagashima, K., Sawa, H., 2005. Dissociation of heterochromatin protein
1 from lamin B receptor induced by human polyomavirus agnoprotein: role in
nuclear egress of viral particles. EMBO Rep. 6, 452–457.
Olsen, G.H., Andresen, P.A., Hilmarsen, H.T., Bjorang, O., Scott, H., Midtvedt, K., Rinaldo,
C.H., 2006. Genetic variability in BK virus regulatory regions in urine and kidney
biopsies from renal-transplant patients. J. Med. Virol. 78, 384–393.
Olsen, G.H., Hirsch, H.H., Rinaldo, C.H., 2009. Functional analysis of polyomavirus BK
non-coding control region quasispecies from kidney transplant patients. J. Med.
Virol. 81, 1959–1967.
Perets, T.T., Silberstein, I., Rubinov, J., Sarid, R., Mendelson, E., Shulman, L.M., 2009.
High frequency and diversity of rearrangements in polyomavirus bk noncoding
20 M.R. Myhre et al. / Virology 398 (2010) 12–20regulatory regions cloned from urine and plasma of Israeli renal transplant
patients and evidence for a new genetic subtype. J. Clin. Microbiol. 47,
1402–1411.
Polo, C., Perez, J.L., Mielnichuck, A., Fedele, C.G., Niubo, J., Tenorio, A., 2004. Prevalence
and patterns of polyomavirus urinary excretion in immunocompetent adults and
children. Clin. Microbiol. Infect. 10, 640–644.
Randhawa, P., Zygmunt, D., Shapiro, R., Vats, A., Weck, K., Swalsky, P., Finkelstein, S.,
2003. Viral regulatory region sequence variations in kidney tissue obtained from
patients with BK virus nephropathy. Kidney Int. 64, 743–747.
Resnick, J., Shenk, T., 1986. Simian virus 40 agnoprotein facilitates normal nuclear
location of the major capsid polypeptide and cell-to-cell spread of virus. J. Virol. 60,
1098–1106.
Rinaldo, C.H., Traavik, T., Hey, A., 1998. The agnogene of the human polyomavirus BK is
expressed. J. Virol. 72, 6233–6236.
Roitman-Shemer, V., Stokrova, J., Forstova, J., Oppenheim, A., 2007. Assemblages of
simian virus 40 capsid proteins and viral DNA visualized by electron microscopy.
Biochem. Biophys. Res. Commun. 353, 424–430.
Rubinstein, R., Pare, N., Harley, E.H., 1987. Structure and function of the transcriptional
control region of nonpassaged BK virus. J. Virol. 61, 1747–1750.Sariyer, I.K., Akan, I., Palermo, V., Gordon, J., Khalili, K., Safak, M., 2006. Phosphorylation
mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J.
Virol. 80, 3893–3903.
Sharma, P.M., Gupta, G., Vats, A., Shapiro, R., Randhawa, P.S., 2007. Polyomavirus BK
non-coding control region rearrangements in health and disease. J. Med. Virol. 79,
1199–1207.
Sundsfjord, A., Spein, A.R., Lucht, E., Flaegstad, T., Seternes, O.M., Traavik, T., 1994.
Detection of BK virus DNA in nasopharyngeal aspirates from children with
respiratory infections but not in saliva from immunodeﬁcient and immunocom-
petent adult patients. J. Clin. Microbiol. 32, 1390–1394.
Tavis, J.E., Walker, D.L., Gardner, S.D., Frisque, R.J., 1989. Nucleotide sequence of the
human polyomavirus AS virus, an antigenic variant of BK virus. J. Virol. 63,
901–911.
Unterstab, G., Gosert, R., Leuenberger, D., Lorentz, P., Rinaldo, C.H., Hirsch, H.H., in
revision. The polyomavirus BK agnoprotein co-localizes with Lipid Droplets.
Yogo, Y., Zhong, S., Xu, Y., Zhu, M., Chao, Y., Sugimoto, C., Ikegaya, H., Shibuya, A.,
Kitamura, T., 2008. Conserved archetypal conﬁguration of the transcriptional
control region during the course of BK polyomavirus evolution. J. Gen. Virol. 89,
1849–1856.
